Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
48 巻, 6 号
選択された号の論文の21件中1~21を表示しています
ORIGINAL ARTICLES
  • Kazuyuki Sakata, Kei Iida, Nao Mochiduki, Yoshihiro Nakaya
    2009 年 48 巻 6 号 p. 393-400
    発行日: 2009年
    公開日: 2009/03/16
    ジャーナル オープンアクセス
    Objective Both brain natriuretic peptide (BNP) and cardiac sympathetic activity are useful surrogate markers of congestive heart failure. BNP is known to be secreted in response to sympathetic tone. This study examined the relationship between the cardiac sympathetic system and BNP.
    Patients and Methods Sixty patients with chronic ischemic heart failure (mean age,72 years-old; 46 males and 14 females) who had undergone cardiac catheterization and were classified as NYHA II underwent resting 99mTc-sestamibi quantitative gated imaging (MIBI) and 123I-metaiodobenzylguanidine imaging (MIBG). MIBI was used to obtain left ventricular (LV) dimension. MIBG was used to obtain the washout rate and the H/M ratios as well as the extent of LV washout rate abnormality (RSNA), which was defined as the number of regions with a regional washout rate of more than mean+2SD of 15 normal subjects on a two-dimensional polar map divided into 20 regions. Blood samples were obtained to measure neurohormones such as BNP, renin activity, noradrenaline, and angiotensin II.
    Results Simple linear regression analysis showed that BNP had significant correlations to age, LVEF, LV end diastolic volume, LV end systolic volume, RSNA, global washout rate, myocardial ischemia, and LV end diastolic pressure. Among them, multiple linear regression analysis showed that only RSNA (partial regression coefficient =0.618, p<0.002) had a significant positive correlation with BNP.
    Conclusion This study suggested that the extent of cardiac sympathetic overactivity in the LV could enhance BNP release.
  • Naohito Tanabe, Kimie Saito, Yukio Yamada, Tetsuya Takasawa, Nao Seki, ...
    2009 年 48 巻 6 号 p. 401-409
    発行日: 2009年
    公開日: 2009/03/16
    ジャーナル オープンアクセス
    Objective To find useful indices to identify subjects at high risk for developing diabetes.
    Methods We retrospectively reviewed 75-g oral glucose tolerance test (OGTT) surveys conducted during 1980 to 2001 in a Japanese community. Using personal charts of the surveys, 230 non-diabetics were followed for progression to type 2 diabetes. The usefulness of HbA1C, fasting (Glucose0) and 1-hour (Glucose60) glucose levels during OGTT, and indices for insulin resistance and/or secretion to identify high risk subjects for diabetes were then analyzed.
    Materials Data described in personal charts of the OGTT program for residents of Nishikawa Town, Niigata Prefecture, Japan.
    Results During the 4.3±2.7 years of follow-up, 52 subjects progressed to type 2 diabetes. Assessing glucose and insulin levels during OGTT, Glucose0, Glucose60, "Insulin Response Ratio" (IRR30, Insulin at 30 minutes / Fasting insulin; IRR60, insulin at 60 minutes / fasting insulin), and insulin secretion / insulin resistance index (ISIRI30) were significantly associated with progression to type 2 diabetes even after the result for OGTT, body mass index, and familial history of diabetes were adjusted. These were also able to identify still higher risk subjects for type 2 diabetes from those with impaired glucose tolerance (IGT) although other indices for insulin resistance or secretion and hemoglobin A1C were less contributable for this purpose.
    Conclusion A combination of Glucose0 and Glucose60 can most cost effectively identify high risk subjects for type 2 diabetes from IGT. IRR30, IRR60 and ISIRI30 can also be used for such identification. However, further studies are needed to clarify whether these indices are superior to Glucose0 and Glucose60.
  • Yuko Watanabe, Hitomi Fujii, Kanemi Aoki, Yasuhiko Kanazawa, Takaichi ...
    2009 年 48 巻 6 号 p. 411-414
    発行日: 2009年
    公開日: 2009/03/16
    ジャーナル オープンアクセス
    Objective Management of chronic kidney disease (CKD) is a critical issue in public health in attempt to prevent kidney failure and dialysis dependency. Since 1998, diabetes mellitus has been the leading cause of dialysis dependency in Japan. Previous reports demonstrated that the prevalence of CKD in diabetic patients was high; however albuminuria was not always present. This cross-sectional survey was performed 1) to indicate the prevalence of CKD and co-morbid illness in diabetic patients seen at diabetic clinics, and 2) to demonstrate the relationship between estimated glomerular filtration rate (eGFR) and urine albumin to creatinine ratio (ACR).
    Patients and Methods A total of 288 consecutive adult type 2 diabetic patients seen at four diabetic clinics in the Tokyo Metropolitan Area were enrolled in November 2007. We excluded patients with kidney failure. Estimated GFR was calculated by the MDRD Study equation with the Japanese coefficient.
    Results Patients had a mean age (+/- SD), 61 (+/- 12); male, 58%; mean BMI, 25.2 kg/m2 (+/- 5.2); and mean HbA1c, 7.1% (+/- 1.3). The prevalence of CKD stage 3 was 38% (109/288) with 64% (70/109) of them being normoalbuminuric. Co-morbid illnesses, including hypertension (p<0.001) and old stroke (p=0.02), were significantly higher in CKD stage 3 patients.
    Conclusion Our patients were relatively young and obese, reflecting urban clinical settings. The prevalence of CKD stage 3 patients was high. Clinicians need to check both eGFR and ACR to avoid underdiagnosis of CKD and diabetic kidney disease.
  • Iwao Ohno, Yuichiro Yamaguchi, Hajime Saikawa, Daijiro Uetake, Miho Hi ...
    2009 年 48 巻 6 号 p. 415-420
    発行日: 2009年
    公開日: 2009/03/16
    ジャーナル オープンアクセス
    Background Sevelamer, a nonabsorbed hydrogel that binds phosphate, is reported to reduce the serum urate concentration in maintenance hemodialysis patients, however the urate-lowering mechanism remains obscure. In this study we verify the urate-lowering effect of sevelamer in Japan in which the hemodialysis environment is different from that of western countries, and we also clarify the urate-lowering mechanism of sevelamer.
    Methods A total of 127 Japanese patients undergoing maintenance hemodialysis were investigated. These patients consisted of 93 males and 34 females, and their mean age was 58.4±12.4 years (range, 25-88 years). The mean duration of hemodialysis was 8.7±6.1 years (range, 0.5-27.5 years). Sevelamer was added to each patient's former prescription for the treatment of hyperphosphatemia, and the changes in laboratory data before and after administration of sevelamer were compared. In order to clarify the mechanism of urate-lowering effect by sevelamer, a urate adsorption experiment was carried out in vitro.
    Results Sevelamer significantly decreased serum phosphate value three and six months after administration. Sevelamer showed a significant reduction in serum urate values in maintenance hemodialysis patients with hyperuricemia, but not in patients with normouricemia. The change rate of serum urate correlated with the change rate of serum phosphate and the change rate of serum calcium × phosphate product, but did not correlate with that of serum calcium. Sevelamer hydrochloride adsorbed urate in vitro.
    Conclusion Sevelamer decreases serum urate possibly by adsorbing urate in hemodialysis patients.
  • Mehmet Derya Demirag, Seminur Haznedaroglu, Banu Sancak, Ceyla Konca, ...
    2009 年 48 巻 6 号 p. 421-426
    発行日: 2009年
    公開日: 2009/03/16
    ジャーナル オープンアクセス
    Objective To investigate the role of circulating hepcidin, which is a homeostatic regulator of iron metabolism and a mediator of inflammation, in anemia associated with rheumatoid arthritis.
    Methods Forty patients with rheumatoid arthritis (19 with anemia and 21 without anemia), 12 patients with iron deficiency anemia and 14 healthy adults were studied. Serum hepcidin levels were analyzed with hepcidin prohormone solid phase enzyme-linked immunosorbent assay.
    Results The mean serum hepcidin levels were significantly higher in patients with rheumatoid arthritis with anemia compared to healthy adults and those with iron deficiency anemia. The active rheumatoid arthritis group had significantly higher mean serum hepcidin levels than the inactive rheumatoid arthritis group. In the rheumatoid arthritis group, serum hepcidin levels were positively correlated with disease activity, but inversely correlated with hemoglobin levels. The serum hepcidin level was found to be a significant predictor for hemoglobin level.
    Conclusion Serum hepcidin levels are closely associated with disease activity in rheumatoid arthritis patients and might play a role in the pathobiology of chronic disease anemia associated with rheumatoid arthritis.
  • Hironobu Yaegashi, Keisaku Fujimoto, Hidetoshi Abe, Kyoko Orii, Sei-ic ...
    2009 年 48 巻 6 号 p. 427-432
    発行日: 2009年
    公開日: 2009/03/16
    ジャーナル オープンアクセス
    Objective The prevalence of complex sleep apnea syndrome (CompSAS) among Asian patients with obstructive sleep apnea syndrome (OSAS) has not yet been reported. Distinguishing CompSAS from pure OSAS is difficult using only diagnostic polysomnography (PSG). We examined the prevalence of CompSAS in Japanese patients with OSAS and the possibility to distinguish CompSAS from pure OSAS by analyzing the severity of respiratory events based on either sleep body position or sleep stage using a diagnostic PSG.
    Patients and Methods A retrospective chart review of 297 consecutive Japanese patients who were 15 years of age or older with a primary diagnosis of OSAS who were referred for CPAP titration (AHI≥20 events/hr).
    Results Seventeen patients (5.7%) out of the 297 patients who had an obstructive apnea hypopnea index (AHI) of 20 or higher showed adverse increases in central apnea index (CAI) by the treatment with CPAP whereas obstructive apnea index (OAI) and mixed apnea index (MAI) were significantly decreased. In the results, the AHI on the PSG for CPAP titration reached only approximately half of the values on the diagnostic PSG. In these CompSAS patients, both the total CAI and the CAI in the supine position during NREM sleep on the diagnostic PSG were significantly higher than those in the OSAS group. The sleep body position did not so strongly affect the AHI, OAI and MAI in the CompSAS group. Multiple, stepwise, and logistic regression analyses revealed that the CAI in the supine position during NREM (p=0.026) was a significant variable to distinguish CompSAS from OSAS statistically although the variables were within the normal range.
    Conclusion The prevalence of CompSAS in Japanese OSAS patients may be lower when compared with Caucasian patients. The increase of CAI in the supine position during NREM sleep on diagnostic PSG may be a characteristic feature in CompSAS.
CASE REPORTS
PICTURES IN CLINICAL MEDICINES
LETTERS TO THE EDITORS
feedback
Top